GE’s contrast dye plant nears 100% capacity

Production of an X-ray imaging dye at a Shanghai plant will resume at normal speed this week after COVID-19-related shutdowns halted supply in May.

Advertisement

As hospitals postpone operations and ration the dye used for about 50 million annual CT scans and other imaging procedures, GE Healthcare expects the global supply of iodinated contrast media to progressively recover in the coming weeks, according to a June 2 press release from the company.

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.